In a major development for the NFL, Jalen Hurts of the Philadelphia Eagles is expected to miss the remainder of the season after doctors diagnosed multiple blood clots in his lungs, including deep vein thrombosis with bilateral pulmonary emboli.

Hurts had flagged a calf injury to medical staff on Oct. 8 following a London practice trip after the Oct. 4 game with the Rams, and he briefly returned to practice before the London trip.

Hurts’ agent Nicole Lynn released a statement saying his condition is stable, with no significant functional limitations, and that treatment involves anticoagulation.

There is an emphasis on transparency in communications to counter potential narratives about recklessness while acknowledging the difficult circumstances.

The article notes fan reactions and includes related Complex coverage and shop/promotional content tied to the story.

There is an offer to arrange conversations with UM experts for media coverage, providing additional context.

The piece references various postgame and pregame press conferences from multiple coaches, framing this as a broad NFL media roundup rather than a single focus.

Pelissero’s reporting is presented as an example of insider storytelling that could obscure mismanagement and endanger players, prompting accountability discussions from the Eagles and the players’ union.

The article commits to updating readers as more information becomes available, including further updates on Dalton and the Eagles.

The text notes media figures and outlets contributing to confusion and underscores the seriousness of potential medical malpractice concerns.

Looking ahead, possible trade or roster considerations include Gardner Minshew, Shedeur Sanders, Mason Rudolph, Anthony Richardson, or Spencer Rattler, depending on team needs and availability.

The recovery path is hopeful despite the seriousness of Hurts’ condition, and the piece criticizes management decisions during an 11-day window surrounding the event.